Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Ovarian Neoplasms
×
trastuzumab deruxtecan
×
Clear all
Filters
3
NCT06819007
2026-03-05
DO-01
Daiichi Sankyo
Phase 3
Recruiting
582 enrolled